Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD

Saved in:
Bibliographic Details
Published inAmerican journal of kidney diseases
Main Authors Stamp, Lisa K., Dalbeth, Nicola, Mount, David B.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 24.07.2024
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0272-6386
1523-6838
1523-6838
DOI:10.1053/j.ajkd.2024.06.005